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Abstract Originally identified as axonal guidance cues,
semaphorins are expressed throughout many different tis-
sues and regulate numerous non-neuronal processes. We
demonstrate that most class III semaphorins are expressed
in mouse osteoblasts and are differentially regulated by cell
growth and differentiation: Sema3d expression is increased
and Sema3e expression decreased during proliferation in
culture, while expression of Sema3a is unaffected by cell
density but increases in cultures of mineralizing osteo-
blasts. Expression of Sema3a, -3e, and -3d is also differ-
entially regulated by osteogenic stimuli; inhibition of
GSK3b decreased expression of Sema3a and -3e, while
1,25-(OH)2D3 increased expression of Sema3e. Parathyroid
hormone had no effect on expression of Sema3a, -3b, or
-3d. Osteoblasts, macrophages, and osteoclasts express the
Sema3e receptor PlexinD1, suggesting an autocrine and
paracrine role for Sema3e. No effects of recombinant
Sema3e on osteoblast proliferation, differentiation, or
mineralization were observed; but Sema3e did inhibit the
migration of osteoblasts in a wound-healing assay. The
formation of multinucleated, tartrate-resistant acid phos-
phatase–positive osteoclasts was decreased by 81% in
cultures of mouse bone marrow macrophages incubated
with 200 ng/mL Sema3e. Correspondingly, decreased
expression of osteoclast markers (Itgb3, Acp5, Cd51,
Nfatc1, CalcR, and Ctsk) was observed by qPCR in mac-
rophage cultures differentiated in the presence of Sema3e.
Our results demonstrate that class III semaphorins are
expressed by osteoblasts and differentially regulated by
differentiation, mineralization, and osteogenic stimuli.
Sema3e is a novel inhibitor of osteoclast formation in vitro
and may play a role in maintaining local bone homeostasis,
potentially acting as a coupling factor between osteoclasts
and osteoblasts.
Keywords Macrophage  Plexin  Mineralization 
Vitamin D3  Migration
Semaphorins are signaling molecules, originally described
as axonal guidance molecules [1], consisting of eight
classes, of which five (classes III–VII) are widely expres-
sed in mammalian tissues [2, 3]. Of these five classes, all
are membrane-tethered except for the secreted class III
semaphorins, which consist of seven members (Sema3a–g)
that display 35–52% protein homology [3]. Similar to other
semaphorins, the class III semaphorins have a sema domain
that interacts with binding domains of receptor complexes
consisting of a plexin (usually of the PlexinA class) and, in
the case of the class III semaphorins alone, a neuropilin
(Npn-1 or -2) [3]. Only Sema3e is capable of binding to a
plexin alone (although notably to PlexinD1, not PlexinA)
without the requirement of a neuropilin [4].
Little is known about the role of the class III semaph-
orins in the skeleton, although several studies have
described expression of some of the family members and
their related receptors. Expression of Sema3a [5, 6],
Sema3b [7], Npn-1 [6, 8], PlexinA1 [6], PlexinA2 [6], and
A. Hughes (&)  J. Kleine-Albers  M. H. Helfrich (&) 
M. J. Rogers
Musculoskeletal Research Programme, School of Medicine &
Dentistry, University of Aberdeen, Institute of Medical Sciences,
Foresterhill, Aberdeen AB252ZD, UK
e-mail: mmd403@yahoo.co.uk
M. H. Helfrich
e-mail: m.helfrich@abdn.ac.uk
S. H. Ralston
Molecular Medicine Centre, Western General Hospital,
University of Edinburgh, Crewe Road, Edinburgh EH42XU, UK
123
Calcif Tissue Int (2012) 90:151–162
DOI 10.1007/s00223-011-9560-7
PlexinD1 [9] has been observed in both primary and cul-
tured osteoblasts. Expression of Npn-1 was not detected in
osteocytes, suggesting that Npn-1 expression is downreg-
ulated during osteoblast differentiation into osteocytes [8].
Sema3a, Npn-1, PlexinA1, and PlexinA2 expression has
been reported in chondrocytes, while only expression of the
receptor components was observed in osteoclasts [6].
Sema3e has been observed in areas of differentiating bone
structures in the mouse embryo [10], although the precise
cell types expressing this protein have not been elucidated.
Here, we describe the expression of class III semapho-
rins and several of their receptors in primary mouse cal-
varial osteoblasts. We demonstrate that expression of
Sema3a, -3d, and -3e is differentially affected by cell
growth or differentiation, 1,25(OH)2D3, and pharmaco-
logical inhibition of GSK3b. Our data confirm that Sema3e
is produced by osteoblasts, may act in an autocrine fashion
to inhibit osteoblast migration, and may act as a paracrine
regulator of osteoclasts due to the inhibitory effects of
recombinant Sema3e on osteoclast formation.
Materials and Methods
Reagents
a-Minimum essential medium (a-MEM), fetal calf serum,
(FCS), penicillin, and streptomycin were from Invitrogen
(Paisley, UK). Tissue culture plates were from Costar
(Cambridge, MA). All other reagents were from Sigma
(Poole, UK), unless otherwise indicated.
Mouse Calvarial Osteoblast Cultures
Osteoblasts were isolated from the calvaria of 4-day-old
litters of C57Bl6 mice by sequential collagenase/EDTA
digestion. Osteoblasts were cultured in a-MEM (10% FCS,
100 U/mL penicillin, 100 mg/mL streptomycin, and 1 mM
glutamine) and grown to *90% confluence. Cells were
harvested in trypsin/EDTA, counted on a Neubauer
hemocytometer, seeded at 3 9 104 cells/cm2, and allowed
to adhere overnight prior to treatment. Mineralization was
induced using a-MEM supplemented with 10% (v/v) FCS,
100 U/mL penicillin, 100 mg/mL streptomycin, 1 mM
glutamine, 10 mM b-glycerophosphate, and 50 lg/mL
L-ascorbic acid 2-phosphate. Medium was replaced every
3 days. Mineralization was visualized by staining with
alizarin red on ethanol-fixed monolayers.
Generation of Mouse Osteoclasts from Bone Marrow
Mouse osteoclasts were generated in vitro from macro-
phage colony-stimulating factor (M-CSF)-dependent bone
marrow macrophages. Bone marrow cells were flushed
from the tibiae and femora of 3- to 4-week-old C57Bl6
mice and cultured overnight in 75-cm2 tissue culture flasks
(one flask per mouse; BD Biosciences, San Jose, CA) in
a-MEM containing 100 U/mL penicillin, 100 lg/mL
streptomycin, 1 mM glutamine, 10% FCS, and 25 ng/mL
murine M-CSF (R&D Systems, Minneapolis, MN). Non-
adherent cells were removed, pelleted, and counted before
being seeded at 1 9 105 cells/cm2 in 75-cm2 tissue culture
flasks in the presence of 25 ng/mL M-CSF. Medium was
changed and fresh M-CSF added every 2 days until con-
fluence, after which cells were trypsinized, counted, and
seeded at 5 9 104 cells/cm2 in a-MEM containing 100 U/
mL penicillin, 100 lg/mL streptomycin, 1 mM glutamine,
10% FCS, 50 ng/mL murine M-CSF, and 10 ng/mL mur-
ine RANKL (R&D Systems). Fresh medium and cytokines
were added every 2 days until multinucleated osteoclasts
formed (approximately 5 days).
Isolation and Culture of Mature Rabbit Osteoclasts
Mature osteoclasts were isolated from the limbs of New
Zealand white rabbits, 2–4 days old, as described previ-
ously [11]. Osteoclasts isolated from the minced long
bones of one rabbit were vortexed and resuspended in
25 mL of a-MEM containing 100 U/mL penicillin, 100 lg/
mL streptomycin, 1 mM glutamine, and 10% FCS. Cells
were seeded in 125-uL aliquots onto 5-mm-diamter dentine
discs before being allowed to adhere for 2 h. Nonadherent
cells were washed away in PBS, before incubation in the
presence or absence of recombinant Sema3e for 48 h. Cells
were then fixed in 4% formaldehyde, stained with TRITC-
phalloidin, and counted for the presence of actin rings by
inverted fluorescence microscopy. Discs were then stained
for tartrate-resistant acid phosphatase (TRAP) as previ-
ously described [12], and TRAP-positive multinucleated
cells with three or more nuclei were considered to be
osteoclasts. Cells were cleaned from the discs, and the area
of resorption pits on the surface of the dentine was quan-
tified by reflected light microscopy and custom image
analysis software developed using Aphelion ActiveX
objects (ADCIS, Herouville-Saint-Clair, France).
Extraction of Total RNA
RNA was extracted by phenol/chloroform fractionation
using TRIzol reagent (Invitrogen) per the manufacturer’s
instructions. Isolated RNA was further purified using an
RNeasy Mini Kit (Qiagen, Valencia City, CA), including a
DNAse I treatment step. RNA quantity was determined by
spectrophotometry, and A260/A280 ratios were used to con-
firm the absence of contamination. RNA quality was con-
firmed on an Agilent (Palo Alto, CA) Bioanalyzer to ensure
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that no degradation occurred during extraction. RNA was
reverse-transcribed to cDNA using 2 lg of total RNA, 1 lg
of random primer oligonucleotides (Invitrogen), and MMLV
reverse transcriptase (SuperScript II, Invitrogen).
End-Point RT-PCR Analysis of Gene Expression
Intron-spanning oligonucleotide primers were designed
using Primer3 [13] and checked via BLAST for specificity
(http://blast.ncbi.nlm.nih.gov/Blast): Sema3e forward, 50-
CCA TAC AAT GCT GCT GGA TG-30; Sema3e reverse,
50-GTG TGC CAA TTA TAT CCG GG-30; PlexinD1
forward, 50-TCA GAG GAG ATC GTG TGT GC-30;
PlexinD1 reverse, 50-GCT CTA TGC TCC AGG TCC TG-
30; Gapdh forward, 50-ACT TTG TCA AGC TCA TTT
CC-30; Gapdh reverse, 50-TGC AGC GAA CTT TAT TGA
TG-30. PCRs were prepared to a total volume of 25 lL
containing the equivalent of 50 ng of reverse-transcribed
RNA per reaction and 500 nM of each primer. Amplifi-
cation was performed using Qiagen Taq DNA polymerase
under optimized conditions: 95C for 10 min, 33 cycles of
95C for 30 s, 58C for 60 s, and 72C for 60 s. Products
were resolved on a 1.5% agarose gel and detected using
ethidium bromide under UV illumination.
Quantitative PCR Analysis of Gene Expression
Intron-spanning, FAM-labeled hydrolysis probe assays
were designed for genes of interest using the Universal
Probe Library (Roche, Mannheim, Germany; see Table 1)
and multiplexed with a primer-limited, VIC-labeled Gapdh
TaqMan assay (Applied Biosystems, Foster City, CA).
Assays were performed on a LightCycler 480 qPCR
system (Roche) using LightCycler Probes Mix and an
optimized protocol (20 lL reaction volume; 5 min 95C,
40 cycles of 10 s 95C, 30 s 60C). Relative gene-of-
interest expression to Gapdh was calculated using a stan-
dard curve of serially diluted cDNA to correct for PCR
efficiency, per the method of Pfaffl [14].
Western Blot Analysis of Sema3e Protein
Protein lysates were prepared in RIPA buffer (1% [v/v]
Nonidet P-40, 0.1% [w/v] sodium dodecyl sulfate, 0.5% [w/
v] sodium deoxycholate in PBS, plus 1% [v/v] protease
inhibitor cocktail [Sigma]). Cell lysate (40 lg) was elec-
trophoresed on 12% polyacrylamide-SDS gels (Criterion XP
system; Bio-Rad, Hemel Hempstead, UK) under reducing
conditions. Proteins were transferred to polyvinylidene
difluoride membranes and then hybridized with 0.2 lg/mL
anti-Sema3E antibody (R&D Systems), followed by 1 lg/
mL anti-goat immunoglobulin G-horseradish peroxidise
conjugate (Merck, Darmstadt, Germany). Bands were
visualized using chemiluminescence (Supersignal West
Dura reagent; Pierce, Rockford, IL) and a Bio-Rad Fluor-S
Max MultiImager.
Measurement of Alkaline Phosphatase Activity
Alkaline phosphatase activity was measured by the con-
version of p-nitrophenyl phosphate to p-nitrophenyl.
Osteoblasts were cultured on 96-well plates and lysed in
150 lL of lysis buffer (1 M diethanolamine [DEA], 1 mM
MgCl2, and 0.05% Triton X-100). Lysate (50 lL) was
mixed with 50 lL of substrate solution (20 mM p-nitro-
phenol phosphate, 1 M DEA, and 1 mM MgCl2). The
amount of p-nitrophenol generated after 30 min was cal-
culated by measuring the absorption of each well at
414 nm in comparison with a standard curve of
1.25–30 nmol/well.
Scratch Wound Assay
A 0.5-mm wound was made, using a pipette tip, across a
confluent monolayer of osteoblasts on 24-well Imagelock
plates (Essen Instruments, Ann Arbor, MI). Cell layers
were washed three times, treated with 40 nM PTH or
100 ng/mL recombinant Sema3e in medium with or with-
out 10% (v/v) serum, incubated in an IncuCyte microscope
(Essen Instruments), and imaged every 30 min. Wound
healing was calculated using the IncuCyte Scratch Wound
Assay software application. Results were confirmed using
replicate plates and images taken on a phase-contrast
inverted light microscope.
Statistical Analysis
One-way analysis of variance (ANOVA) followed by a
(Bonferroni/Dunnett’s) post hoc test was used to statisti-
cally analyze results using SPSS version 15.0 software
(SPSS, Inc., Chicago, IL). P B 0.05 was considered sta-
tistically significant.
Results
Expression of Class III Semaphorins in Mouse
Calvarial Osteoblasts
Using a panel of quantitative PCR (qPCR) assays to measure
all seven known members of the class III semaphorins, we
examined their expression profile in both proliferating
(P, after 48-hour growth in normal medium) or mineralizing
(M, after 14 additional days in osteoblast differentiation
medium) C57Bl6 calvarial osteoblasts (Fig. 1a). Six of the
seven class III semaphorins were detected in osteoblasts (the
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exception being Sema3f), as was expression of the receptor
components PlexinA1 and -D1. Sema3c was the most
abundant, with low levels of Sema3b, -3d, and -3 g detected
in proliferating osteoblasts. Fourteen days treatment in dif-
ferentiation medium resulted in mineralization (as confirmed
by alizarin red staining) (data not shown) and a significant
increase in expression of Sema3a, -3d, and -3 g as well as
PlexinD1 (by 2.2-, 14.6-, 6.5-, and 4.6-fold, respectively).
Sema3e significantly decreased by 90% in mineralizing
cultures, while Sema3c remained unchanged and Sema3f
remained undetected. We chose three of the significantly
regulated genes for further investigation, choosing Sema3a,
-3d, and -3e based on reports of each displaying effects on
cells or in tissues unrelated to axonal guidance.
Long culture periods ([1 week) in the presence of dif-
ferentiation medium are required to produce cultures of
mineralizing osteoblasts. In order to discount the effects of
culture time or cell density on the expression of key members
of the class III semaphorins, we examined expression of
Sema3a, -3d, and -3e in osteoblasts seeded at a low density
and grown toward confluence in normal, nondifferentiation
medium (Fig. 1b). Osteoblasts proliferated until confluence
at 96–120 h postseeding and remained viable during the time
course. Expression of Sema3a remained unchanged, while
3d significantly increased in expression to 11.2-fold over
control by 216 h. Sema3e significantly decreased in
expression as cells grew to confluence, reaching a fivefold
decrease by 216 h. After reaching confluence, expression of
both Sema3d and -3e stabilized. These observations suggest
that the changes in expression of Sema3d and -3e observed in
cultures of proliferating and mineralizing cultures were
related to the effects of cell growth and density and that the
increase in Sema3a expression in mineralizing cultures was
not related to cell growth or density.
Sema3a, -3d, and -3e Are Differentially Regulated
by Osteogenic Factors
Next, we examined the expression of Sema3a, -3d, and
-3e in response to factors known to influence osteoblast
differentiation. PTH may act as both an anabolic and a
catabolic factor in bone, depending on the timing and
duration of exposure [15]. Short-term exposure of cal-
varial osteoblasts to PTH induced an elevation of alkaline
phosphatase activity (data not shown), indicating that
osteoblast differentiation had been initiated [16]. Despite
this, we did not see an effect on the expression of
Sema3a, -3d, or -3e after 24-hour exposure (Fig. 2a–c) or
at earlier or later time points (data not shown) following
PTH stimulation. Proliferation and differentiation of
osteoblasts in vitro can also be induced by 1,25-di-
hydroxyvitamin D3 (1,25[OH]2D3) treatment [17, 18] and
has previously been reported to regulate Sema3b expres-
sion in osteoblasts [7]. In contrast to the inert effects of
PTH, 1,25(OH)2D3 caused a significant increase in
expression of Sema3e after 24 h (Fig. 2c), which persisted
for at least 48 h posttreatment (data not shown) but had
no effect on Sema3a or 3d expression (Fig. 2a, b).
Stimulation of the canonical Wnt signaling pathway
promotes the translocation of b-catenin to the nucleus and
the subsequent regulation of gene transcription via bind-
ing to TCF/LEF. Wnt signaling is important in the
development and maintenance of mineralized tissues [19]
and has previously been implicated in the regulation of
Sem3d in zebrafish [20] and Sema3a in the dental mes-
enchyme [21] but has not been investigated in osteoblasts
in vitro. Downstream stimulation of the canonical Wnt
pathway can be achieved by pharmacological inhibition of
GSKb (which phosphorylates b-catenin to target it for
ubiquitin-mediated degradation [22]) by 6-bromoindiru-
bin-30-oxime (BIO) [23]. Treatment with MeBIO, the
kinase inactive negative control of BIO, had no significant
effect on expression of Sema3a, -3d, or -3e, while BIO
caused a significant decrease in expression of both
Sema3a and -3e (Fig. 2a, c). Cells were also treated with
40 mM LiCl, which inhibits GSKb but via a different
mechanism from BIO. LiCl inhibition of GSKb also
caused a decrease in Sema3a and -3d expression, sup-
porting the data observed with BIO (data not shown).
These data demonstrate that there is evidence of
Table 1 Universal Probe Library assays for quantitative PCR
Gene Forward primer Reverse primer UPL probe
Sema3a 50-ATC AGT GGG TGC CTT ACC AA 50-GCC AAA TGT TTT ACT GGG ACA 72
Sema3b 50-CTT CGG CTC TCC TTT CAA GA 50-CAA GGC TTC ATA ACA GCA GGT 19
Sema3c 50-ATG GCC ACT CTT GCT CTA GG 50-CAT CTT GTC TTC GGC TCC TC 48
Sema3d 50-GGA AAA GCG ACA AGA GTT GC 50-TGA AAA TTT TGT TTT TCA AAC ACT G 4
Sema3e 50-GGG GCA GAT GTC CTT TTG A 50-AGT CCA GCA AAC AGC TCA TTC 63
Sema3f 50-GAA GGA GGA ACG CGG AAG 50-AGG CAG TGA CAA GCA TCG T 38
Plexina1 50-CGC CAA GTC CAA GGA CGA G 50-CTG CCT TCG AGC CTG TTC 21
Plexind1 50-CTG GAT GTC CAT CTG CAT GT 50-CAG GAA GAA CGG CTC ACC TA 27
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differential regulation of class III semaphorins in response
to modulation of signaling pathways known to be
important for osteoblast function.
Expression of Sema3e and Its Associated Receptor,
PlexinD1, in Bone Cells
As Sema3b has recently been reported to be a
1,25(OH)2D3-responsive gene in osteoblasts [7], we deci-
ded to focus on the similarly 1,25(OH)2D3-responsive
Sema3e for further study. Sema3e is a unique class III
semaphorin as it does not require the presence of a neu-
ropilin in its receptor complex, instead consisting solely of
PlexinD1. Since class III semaphorins can antagonize
VEGF signaling by competing for neuropilins, Sema3e will
not exhibit non-Plexin-mediated effects associated with
neuropilin sequestration, thereby avoiding potential inter-
pretation problems due to the expression of VEGF recep-
tors in osteoblasts (reviewed in [24]). Sema3e expression
was strongly detected in osteoblasts by both end-point and
qPCR but below the limit of detection in macrophages and
osteoclasts (Fig. 3a, b). Sema3e protein was clearly
detected in both proliferating and mineralizing osteoblast
cultures but not osteoclasts (Fig. 3d). Trace amounts of
Sema3e protein were detected in macrophage cultures,
possibly representing some heterogeneity within the cell
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Fig. 1 Differential expression
of semaphorin class III
members in proliferating or
mineralizing mouse osteoblasts.
a Calvarial osteoblasts were
treated during proliferation
(P) or mineralizing state
(M, after 14 days in
b-glycerophosphate- and
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medium) and harvested for
RNA to generate cDNA.
Quantitative PCR was
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expression of class III
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population. Higher protein levels were observed in cultures
of mineralizing osteoblasts compared to proliferating
osteoblasts, despite the lower transcript expression
observed in mineralizing cultures, although this may be due
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Fig. 3 Expression of Sema3e and its receptor PlexinD1 in mouse
bone cells. Mouse macrophages (Macs), osteoclasts (OCs), prolifer-
ating calvarial osteoblasts (OBs), and mineralizing calvarial osteo-
blasts (MOBs, 14 days in b-glycerophosphate- and ascorbic acid–
supplemented medium) were harvested for protein and RNA. a
End-point PCR showing Sema3e and PlexinD1 expression in all four
cell types. Quantitative-PCR showing relative abundance of b Sema3e
or c PlexinD1 in bone cells in vitro, both normalized to Gapdh and
calibrated to the expression observed in OBs. d Western blot of
Sema3E protein expression in lysates generated from identical
samples used in PCR analysis. Representative blots are from three
independent experiments (a, d) and from three independent exper-
iments with triplicate technical replicates (b, c). *p \ 0.05,;
**p \ 0.01, ***p \ 0.001
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to deposition and accumulation of secreted Sema3e in the
extracellular matrix. All cell types examined (osteoblasts,
M-CSF-dependent macrophages, and osteoclasts) expres-
sed the Sema3e receptor protein PlexinD1 (Fig. 3a).
Expression of PlexinD1 was significantly higher in mac-
rophages and osteoclasts than in either osteoblast culture
(Fig. 3c). As expression of PlexinD1 was detected in all
cells, this suggests that osteoblast-derived Sema3e may act
as both an autocrine signaling molecule and in a paracrine
manner upon macrophages and/or osteoclasts. We found no
change in expression of PlexinD1 after treatment with
1,25(OH)2D3, BIO, or PTH (data not shown) and encoun-
tered problems detecting PlexinD1 protein levels in mouse
cells using available antibodies.
Recombinant Sema3e Decreases the Migration
of Osteoblasts
Since osteoblasts expressed both Sema3e and PlexinD1, we
investigated Sema3e as an autocrine regulator of osteoblast
function in vitro. Recombinant mouse Sema3e (100 ng/
mL) did not affect osteoblast proliferation, measured by
alamar blue assay of viable cell number (data not shown),
nor did it affect mineralization, measured by alizarin red
staining after 7, 14, or 21 days in culture (21-day repre-
sentative image shown in Fig. 4a). PTH (40 nM) caused
differentiation of osteoblasts and a subsequent doubling in
alkaline phosphatase activity after 48-hour treatment.
Sema3e (100 ng/mL) did not affect alkaline phosphatase
activity in the presence or absence of PTH (Fig. 4b) but did
inhibit the migration of osteoblasts in a wound-healing
assay using a confluent monolayer of osteoblasts. PTH
increased wound healing, and serum-free medium resulted
in no migration of cells into the wound area (Fig. 4c). As
wound closure can occur as a result of both migration and
proliferation, it was important to establish that the effects
observed in Fig. 4c were predominantly due to migration.
By constructing time-lapse videos from the still images
taken for calculating wound width, we could confirm that
wound closure occurred due to migration of cells across the
wounded region and not due to proliferation of cells along
the wound edges (data not shown).
Recombinant Sema3e Decreases the Formation
of Osteoclasts
As macrophages and osteoclasts express PlexinD1, we next
investigated the effect of 200 ng/mL recombinant mouse
Sema3e protein on the formation of multinucleated (three
or more nuclei per cell), TRAP-positive osteoclasts in
M-CSF- and RANKL-treated cultures of mouse bone
marrow macrophages. An abundance of TRAP-positive
osteoclast-like cells was observed in control cultures after
approximately 5 days in RANKL, while Sema3e-treated
cultures had fewer osteoclasts and less intense TRAP
staining (Fig. 5a), which was confirmed by Western blot-
ting for TRAP protein (Fig. 5b). Quantification of osteo-
clasts revealed that Sema3e-treated cultures had 62% fewer
osteoclasts than control cultures (Fig. 5c), with a dose-
dependent decrease in osteoclast number observed from 50
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to 200 ng/mL (data not shown). Accordingly, qPCR anal-
ysis showed that genes associated with osteoclast formation
and differentiation were 25–40% lower in Sema3e-treated
cultures compared to control cultures, with significant
decreases observed in Acp5, Cd51, Nfatc1, and Calcr
expression (Fig. 5d). All markers in Fig. 5d were
substantially upregulated in M-CSF- and RANKL-stimu-
lated osteoclast cultures compared to M-CSF-treated
cultures alone (from undetectable levels of Calcr to
100 ? -fold increases in Alp5, Mmp9, and Ctsk and a
twofold increase in Nfatc1 and Cd51), confirming the for-
mation of osteoclast cells in M-CSF and RANKL cultures
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(data not shown). In order to ascertain if Sema3e could
affect osteoclast function as well as formation, we inves-
tigated the effects of Sema3e treatment on mature osteo-
clast cultures. As mature osteoclast cultures from mice
formed variably on dentine, we used mature osteoclasts
isolated from the minced long bones of rabbit neonates to
remove errors associated with varying formation efficien-
cies or the inhibitory effects of Sema3e on formation. The
use of mature rabbit osteoclasts on dentine is an established
method for the measurement of resorption, enabling the
easy identification of TRAP-positive osteoclasts and
functional actin rings. No effect of Sema3e was observed
on the number of TRAP-positive multinucleated cells
adhered to the dentine surface, the formation of actin rings,
or the area of dentine resorbed by mature osteoclasts
(Fig. 6a–c).
Discussion
Functional roles independent of axonal guidance have been
found for numerous semaphorins, and class III members
have been implicated in vascular patterning [4], angio-
genesis ([25], reviewed by [26]), immune responses
including T-cell activation ([27], reviewed by [28]), and
the regulation (both positive and negative) of cancer cells
([10, 25, 29, 30], reviewed by [31]). Some of these roles
may be attributable to antagonism of VEGF signaling due
to competition for neuropilins, which are coreceptors for
both VEGF and most class III semaphorin receptor com-
plexes [32–34]. As the receptor complex for Sema3e con-
sists only of PlexinD1 and does not require a neuropilin
cofactor, any pleiotropic effects of Sema3e cannot be due
to interference with VEGF signaling [4].
Wnt signaling is an important mediator of osteoblast
differentiation and can signal either through canonical
(b-catenin-dependent) or noncanonical (b-catenin-inde-
pendent) pathways. Sema3a is positively regulated by
Wnt4 in the dental mesenchyme [21], although it is unclear
if this is via canonical or noncanonical Wnt signaling.
Sema3d has been suggested to be downstream of Wnt
signaling via TCF in zebrafish neural crest cells, indicating
a possible role of canonical Wnt signaling in the positive
regulation of Sema3d [22]. Contrary to what has been
observed in the dental mesenchyme or zebrafish hindbrain,
activation of the canonical Wnt signaling pathway via
pharmacological inhibition of GSKb resulted in decreased
Sema3a and -3e expression and had no effect on Sema3d in
mouse calvarial osteoblasts. This indicates that there may
be differential regulation of class III semaphorins down-
stream of canonical or noncanonical Wnt signaling and/or
cell- or tissue-type differences in regulation. Our results
demonstrate for the first time that at least two members of
the class III semaphorins, Sema3a and -3e, are transcrip-
tionally repressed following upregulation of b-catenin
signaling mouse; but the functional consequences of this
remain to be elucidated.
While previous studies have focused on the effects of
semaphorins on osteoclast formation and function [7, 35],
we investigated the effects of recombinant Sema3e directly
on osteoblasts. Since expression of PlexinD1 increased
during differentiation of calvarial osteoblasts, we reasoned
there may be an autocrine role for Sema3e in osteoblast
formation/function. Autocrine actions of class III sem-
aphorins have been demonstrated to regulate the survival of
kidney podocytes [36]. Sema3a acts in an autocrine fashion
in several tumor types, causing dispersal of glioblastoma in
a Rac1-dependent manner [37], stimulating adhesion via
the a2b1 integrin in breast cancer cells [38], and regulating
the angiogenic potential of endothelial cells [25]. Here, we
demonstrate that Sema3e can affect osteoblasts in an auto-
crine fashion, inhibiting migration but not proliferation,
0
25
50
75
100
125
150
Control 200ng/ml
Sema3e
Tr
ap
 p
os
iti
ve
 c
el
ls
 
(p
er
ce
nt
ag
e o
f c
on
tro
l)
0
25
50
75
100
125
150
Control 200ng/ml
Sema3e
A
ct
in
 ri
ng
 n
um
be
r
(p
er
ce
nt
ag
e o
f c
on
tro
l)
0
25
50
75
100
125
150
Control 200ng/ml
Sema3e
N
or
m
al
iz
ed
 re
so
rp
tio
n
(p
er
ce
nt
ag
e o
f c
on
tro
l)
A B C
Fig. 6 Effects of recombinant Sema3e on mature rabbit osteoclast
resorption. Mature rabbit osteoclasts were isolated from the long
bones of neonatal rabbits allowed to attach on dentine discs, then
treated with or without 200 ng/mL recombinant Sema3e for 48 h.
a Osteoclast number was determined by TRAP staining (TRAP? and
three or more nuclei per cell). b Actin rings were quantified by
phalloidin staining for actin. c Total resorbed area of dentine was
normalized to the number of TRAP? cells adhered to each disc.
Results are from two independent experiments with eight replicates
per experiment
A. Hughes et al.: Sema3e Inhibits Osteoblasts and Osteoclasts 159
123
resulting in a decreased reclamation of wound area in a
scratch assay. Negative regulation of migration by class III
semaphorins has been observed before, with Serini et al. [39]
demonstrating the ability of Sema3a to inhibit the adhesion
and migration of chick embryo endothelial cells due to
altered activation of b1 integrins. Sema3e is known to inhibit
the migration of CD69? thymocytes toward CCL25 and
CCL21 chemokines in a pathway involving PlexinD1 [40].
However, furin-dependent processing of Sema3e results in a
truncated p61-Sema3e protein that promotes endothelial cell
migration [41], suggesting that individual semaphorins may
have differential effects on migration depending on the
processing of the protein. We used full-length recombinant
Sema3e in our osteoblast cultures and observed a negative
effect on cell migration, but we do not know if Sema3e is
processed in a similar fashion to that observed by Christen-
sen et al. [41] or whether this would alter the effects observed
by cleavage to the p61-Sema3e form.
Little is known about the effects of semaphorins on bone
development and homeostasis, although there is accumu-
lating evidence of their involvement. Knockout mouse
models have revealed rib-patterning and vertebral body
defects in Sema3a [42] and PlexinD1 [9] knockout mice,
which may be due to developmental defects in axial
skeletogenesis. Sema3a signaling in rat bone both tempo-
rally and spatially coincides with infiltration of bone with
blood vessels and nerve fibers [6], suggesting defective
innervation and perfusion might be the cause of the defects
observed in Sema3a knockout mice. That PlexinD1 mice
display a skeletal phenotype might suggest an involvement
of Sema3e in skeletogenesis but may also be secondary to
observed vascular defects [43]. PlexinA1 knockout mice do
not display the same morphological defects as Sema3a and
PlexinD1 knockout mice but have an osteopetrotic phe-
notype due to decreased osteoclast number and activity
attributable to defective Sema6d, but not Sema3a, signaling
[44].
Only a recent publication by Sutton et al. [7] has dem-
onstrated a clear role for a class III semaphorin in the direct
local regulation of bone homeostasis: osteoblast-targeted
expression of Sema3b-induced ostoeclastogenesis resulting
in a osteopenic mouse model, while Sema3b transgenic
osteoblasts displayed increased differentiation and miner-
alization compared to wild-type cells in vitro. Similar to
Sutton et al. [7], we confirmed expression of Sema3b in
osteoblasts and observed an increase in Sema3b expression
in response to differentiation, although our results suggest
that cell density and time in culture may be more important
factors for the regulation of Sema3d and Sema3e expres-
sion than osteoblast differentiation. As Sema3a did not
alter in expression during growth, the significant increase
in expression in mineralizing cultures appears to be due
solely to differentiation. However, no change in Sema3a
expression was observed after treatment with PTH or
1,25(OH)2D3, both of which have known effects on
osteoblast differentiation. We did observe an increase in
Sema3e in response to 1,25(OH)2D3 treatment, as did
Sutton et al. [7] for Sema3b. Sutton et al. [7] reported an
increase in Sema3b expression within 3 h of treatment,
while we did not observe any changes in Sema3e expres-
sion until much later time points. We observed no change
in expression of Sema3a or -3d in response to 1,25(OH)2D3
treatment, demonstrating that some, but not all, class III
semaphorins are regulated either directly (as is likely for
Sema3b) or indirectly (i.e., Sema3e) by 1,25(OH)2D3. In
contrast to Sutton et al. [7], we observed a negative effect
of Sema3e on osteoclast formation, suggesting that Sema3e
may act in opposition to Sema3b, which would be sup-
ported by the significant decrease in Sema3e expression in
mineralizing osteoblasts, while Sema3b tends to decrease.
This raises the possibility that Sema3e acts as a negative
regulator of bone resorption during increased bone for-
mation, while Sema3b may promote osteoclast formation
during times of osteoblast quiescence. Further studies are
needed to determine whether the relative expression of
Sema3e and -3b (plus, indeed, other class III semaphorins)
acts as a metaphorical weight on the seesaw of bone
turnover, tipping the balance in favor of resorption or
formation.
We have established that all, with the exception of
Sema3f, class III semaphorins are expressed by osteoblasts
and that they may all be differentially regulated by cell
growth, differentiation, and diverse signaling pathways
essential for the maintenance of bone homeostasis. Fur-
thermore, we suggest an autorine effect on osteoblast
migration and a role for Sema3e as a paracrine mediator of
osteoclast formation. We observed a 10-fold increase in
Sema3d expression in mineralizing cultures that correlates
with increasing cell density. As Sema3d is regulated in the
opposite direction from Sema3e, it would be interesting to
observe if Sem3d has opposing effects on osteoclast for-
mation compared to Sema3e. However, as Sem3d expres-
sion was unaffected by treatment with PTH, BIO, or
1,25(OH)2D3, we did not investigate this protein further. In
addition, as Sema3d would signal via the involvement of
both a plexin and a neuropilin [45], we would not be able to
easily rule out the involvement of antagonism with VEGF
signaling on any observed effects. VEGF is known to
enhance osteoclast activity and survival [46], indicating
that competition between the Sema3d receptor complex
and the VEGFR for neuropilins could have confounding
effects on osteoclast cultures. Previous reports have sug-
gested no effect of Sema3a on osteoclasts [44], while
Sema3b appears to be a strong regulator of osteoclast
formation [7]. Our data indicate that Sema3b is not the only
class III semaphorin to have effects on osteoclast function
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but that it has opposing effects to those demonstrated by
Sutton et al. [7] with Sema3b. This raises the possibility
that not only are class III Sema proteins important in
coupling osteoblast and osteoclast activity but there might
also be opposing actions on bone turnover dependent on
the expression of the class III Sema proteins themselves
and the nuances of the receptor complexes with which they
interact.
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